IPO launch on Euronext Paris

IPO launch on Euronext Paris

AFFLUENT MEDICAL launches its IPO on the regulated Euronext Paris market • Capital increase of approximately €33.0 million, which may be increased to approximately €43.6 million in the event of the full exercise of the extension and over-allotment clause •...
Epygon publication

Epygon publication

Affluent Medical published preclinical data in the renowned ANNALS OF THORACIC SURGERY confirming the potential of its Epygon mitral valve to restore blood flow and reduce the risk of cardiac insufficiency. • Preclinical in vivo results published in The Annals of...
Approval of the Registration Document

Approval of the Registration Document

AFFLUENT MEDICAL announces the approval of its Registration Document by the French Financial Markets Authority (Autorité des marchés financiers – AMF) as part of its proposed IPO on the Euronext Paris regulated market Affluent Medical, a French medtech specialising in...